What ProMIS Neurosciences Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 11 |
| Sells | 0 | 0 |
| Total trades | 3 | 16 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 37,816 | 774,476 |
| Disposed | 0 | 0 |
| Net activity | +37,816 | +774,476 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Williams Eugene | Director | Nov 04 | Open-market buy · P | +26,500 | $3.43 | +$90.9K | 40,213 |
| Cashman Neil | Chief Scientific Officer | Nov 02 | Open-market buy · P | +10,000 | $3.86 | +$38.6K | 14,532 |
| Williams Eugene | Director | Oct 30 | Open-market buy · P | +1,316 | $3.99 | +$5.25K | 13,713 |
| Kaplan Johanne | Chief Development Officer | Aug 05 | Open-market buy · P | +2,280 | $13.30 | +$30.3K | 6,221 |
| Kirwin Patrick D. | Director | Apr 22 | Open-market buy · P | +4,000 | $11.33 | +$45.3K | 4,653 |
| Williams Eugene | Director | Mar 05 | Open-market buy · P | +2,000 | $24.40 | +$48.8K | 12,397 |
| Williams Eugene | Director | Mar 04 | Open-market buy · P | +2,000 | $24.00 | +$48K | 10,397 |
| Williams Eugene | Director | Mar 03 | Open-market buy · P | +1,000 | $21.89 | +$21.9K | 8,397 |
| Williams Eugene | Director | Mar 02 | Open-market buy · P | +1,000 | $22.53 | +$22.5K | 7,397 |
| Kaplan Johanne | Chief Development Officer | Feb 19 | Open-market buy · P | +1,629 | $15.35 | +$25K | 3,941 |
| Milbury Max A. | Insider | Feb 03 | Grant / award · A | +6,595 | $12.13 | +$80K | 8,409 |
| Kirwin Patrick D. | Director | Feb 03 | Grant / award · A | +3,050 | $12.13 | +$37K | 5,135 |
| Warma Neil K | Chief Executive Officer | Feb 03 | Grant / award · A | +6,183 | $12.13 | +$75K | 6,183 |
| Kaplan Johanne | Chief Development Officer | Feb 03 | Grant / award · A | +2,060 | $12.13 | +$25K | 2,312 |
| Cashman Neil | Chief Scientific Officer | Feb 03 | Grant / award · A | +4,122 | $12.13 | +$50K | 4,122 |
| Abg Management Ltd. | 10% owner | Feb 03 | Open-market buy · P | +700,741 | $12.13 | +$8.5M | 943,090 |
| Milbury Max A. | Insider | Oct 03 | Open-market buy · P | +30,392 | $0.49 | +$14.9K | 45,389 |
| Sclar Jeremy M. | 10% owner | Jul 25 | In/At-money Exercise · X | +697,674 | — | — | 3,710,459 |
| Sclar Jeremy M. | 10% owner | Jul 25 | In/At-money Exercise · X | +697,674 | — | — | 3,012,785 |
| Sclar Jeremy M. | 10% owner | Jul 25 | In/At-money Exercise · X | +697,674 | — | — | 2,315,111 |
Loading...